C. Zhao

Synthesis and inhibitory action on HMG-CoA synthase of racemic and optically active oxetan-2-ones (beta-lactones).

G. Wright, P. H. Harrison, S. Jenkins, 1998, Bioorganic & medicinal chemistry.

Design of orally bioavailable, symmetry-based inhibitors of HIV protease.

S. Vasavanonda, D. Kempf, H. Sham, 1994, Bioorganic & medicinal chemistry.

Potent HIV-1 protease inhibitors with antiviral activities in vitro.

S. Vasavanonda, D. Norbeck, D. Kempf, 1991, Biochemical and biophysical research communications.

A novel, picomolar inhibitor of human immunodeficiency virus type 1 protease.

A. Molla, S. Vasavanonda, N. Lyons, 1996, Journal of medicinal chemistry.

Lack of pharmacokinetic interactions of aliskiren, a novel direct renin inhibitor for the treatment of hypertension, with the antihypertensives amlodipine, valsartan, hydrochlorothiazide (HCTZ) and ramipril in healthy volunteers

S. Vaidyanathan, M. Bizot, W. Dole, 2006, International journal of clinical practice.

Discovery of ritonavir, a potent inhibitor of HIV protease with high oral bioavailability and clinical efficacy.

A. Molla, S. Vasavanonda, D. Norbeck, 1998, Journal of medicinal chemistry.

Novel azacyclic ureas that are potent inhibitors of HIV-1 protease.

A. Molla, S. Vasavanonda, D. Norbeck, 1996, Biochemical and Biophysical Research Communications - BBRC.